North America Multiplex Assays Market

North America Multiplex Assays Market Size

The size of the North America multiplex assays market was worth USD 1.30 billion in 2024. The North America market is anticipated to grow at a CAGR of 6.57% from 2025 to 2033 and be worth USD 2.30 billion by 2033 from USD 1.39 billion in 2025.

MARKET DRIVERS

The Growing Preference for Multiplex Assays Over Singleplex Assays Is Driving the North America Market

Factors such as the benefits associated with the multiplex assays over the conventional singleplex assays are expected to offer substantial growth in North America. The growing number of immunoassays tests performed and Y-O-Y growth in the incidence rate of chronic and infectious diseases are estimated to propel the market growth during the forecast period. Increasing healthcare expenditure and adopting advanced technologies in the healthcare infrastructure in this region further accelerate market growth.

MARKET RESTRAINTS

Refractive errors and the shortage of skilled and experienced professionals hinder the multiplex assays market growth in this region.

COUNTRY LEVEL ANALYSIS

North America accounts for the largest share of the market. The key factors that drive this market's growth include an increase in the pool of patient population, a rise in the prevalence of Alzheimer patients, and a significant rise in pharmaceuticals research & development activities to treat diseases like cancer and Alzheimer’s.

The U.S. is estimated to rule the North America multiplex assay market due to the government's initiatives in enhancing precision medicine in advance with strategic partners among the critical players in contesting for multiplex assay development. Rising old people population which foster the market.

The Canadian market is predicted to have maximum growth over the historical period. Frequency of cancer cases, investments made by the government for the R&D towards the drug discovery, and the treatment, necessity for the multiplex assay will augment the region as it is a useful oncology tool that fuels the market growth during the assessment period.

KEY MARKET PLAYERS

Companies playing a dominant role in the North America Multiplex Assays Market profiled in this report are Luminex Corporation, Thermo Fisher Scientific Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Abcam Plc, Becton, Dickinson and Company, Luminex Corporation, Meso Scale Diagnostics, Randox Laboratories Ltd, and Seegene Inc.

MARKET SEGMENTATION

This research report on the North America multiplex assays market is segmented and sub-segmented into the following categories.

By Product

• Consumable

• Kits & Reagents

• Panels

By Type

• Nucleic Acid-Based

• Protein-Based

By Technology

• PCR

• Multiplex Array

By Application

• R&D

• Companion Diagnostics

By End User

• Hospital

• Clinical Laboratory

By Country

• United States
• Canada
• Mexico
• Rest of North America